Baseline clinical characteristic | Patient nr. 150 |
---|---|
Age (years)—mean ± SD | 64.3 ± 10.4 |
Sex (male)—no. (%) | 108 (72.0) |
Race (Caucasian)—no. (%) | 140 (93.3) |
Body-mass index (kg/m2)—mean ± SD; no. | 29.5 ± 5.1; 148a |
Risk factors—no. (%) | |
 Diabetes mellitus type 1 | 10 (6.7) |
 Diabetes mellitus type 2 | 140 (93.3) |
 Insulin-dependent diabetes mellitus | 47 (31.3) |
 Diabetes mellitus treated with oral antidiabetic | 117 (78.0) |
 HbA1c (mmol/mol)—mean ± SD; no. | 55.5 ± 11.5; 42a |
 Arterial hypertension | 104 (69.3) |
 Hypercholesterolemia | 100 (66.7) |
 Family history of cardiovascular disease | 59 (39.3) |
 Current smoker | 35 (23.3) |
Medical history—no. (%) | |
 Previous ACS | 41 (27.3) |
 Previous PCI | 37 (24.7) |
 Previous CABG | 8 (5.3) |
 Previous CVA or TIA | 10 (8.7) |
 Severe chronic renal failureb | 4 (2.7) |
 Chronic pulmonary obstructive diseasec | 11 (7.3) |
Clinical presentation—no. (%) | |
 Acute coronary syndrome | 73 (48.7) |
  ST-segment elevation myocardial infarction | 18 (12.0) |
  Non-ST-segment elevation myocardial infarction | 29 (19.3) |
  Unstable angina pectoris | 26 (17.3) |
 Non-acute coronary syndrome | 77 (51.3) |
  Stable angina pectoris | 59 (39.3) |
  Silent ischemia | 8 (5.3) |
  Other | 10 (6.7) |